Cargando…
Use of Lipid-Lowering Therapies Over 2 Years in GOULD, a Registry of Patients With Atherosclerotic Cardiovascular Disease in the US
IMPORTANCE: Guidelines for patients with atherosclerotic cardiovascular disease (ASCVD) recommend intensive statin therapy and adding nonstatin therapy if low-density lipoprotein cholesterol (LDL-C) levels are 70 mg/dL or more. Compliance with guidelines is often low. OBJECTIVE: To track LDL-C treat...
Autores principales: | Cannon, Christopher P., de Lemos, James A., Rosenson, Robert S., Ballantyne, Christie M., Liu, Yuyin, Gao, Qi, Palagashvilli, Tamara, Alam, Shushama, Mues, Katherine E., Bhatt, Deepak L., Kosiborod, Mikhail N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209562/ https://www.ncbi.nlm.nih.gov/pubmed/34132735 http://dx.doi.org/10.1001/jamacardio.2021.1810 |
Ejemplares similares
-
What Do US Physicians and Patients Think About Lipid‐Lowering Therapy and Goals of Treatment? Results From the GOULD Registry
por: Arnold, Suzanne V., et al.
Publicado: (2021) -
Use of lipid‐lowering therapies in patients with chronic kidney disease and atherosclerotic cardiovascular disease: 2‐year results from Getting to an imprOved Understanding of Low‐Density lipoprotein cholesterol and dyslipidemia management (GOULD)
por: Shaik, Aleesha, et al.
Publicado: (2022) -
Adherence to Guideline Medication Recommendations to Prevent Atherosclerotic Cardiovascular Disease Progression Among Adults With Prior Myocardial Infarction
por: Arnold, Suzanne V., et al.
Publicado: (2020) -
Intensity of Lipid-Lowering Therapy Among Patients With Polyvascular Disease
por: Peterson, Benjamin E., et al.
Publicado: (2023) -
Gould’s Dictionary
Publicado: (1912)